Table 3.
CPT1A | DGAT1 | ELOVL2 | ELOVL5 | FADS1 | FADS2 | FASN | INSR | PPARA | |
---|---|---|---|---|---|---|---|---|---|
14:0 |
0.56*** |
|
|
0.40* |
0.39* |
0.34* |
|
0.32* |
|
14:1c9 |
|
|
|
|
|
|
0.42** |
|
|
16:0 |
0.60*** |
|
0.44** |
0.60*** |
0.42** |
|
|
|
|
16:1c7 |
|
|
|
|
0.48** |
0.44** |
|
|
|
16:1c9 |
0.47** |
|
0.37* |
0.51*** |
0.38* |
|
|
|
|
17:0 |
|
|
−0.37* |
|
|
|
|
|
|
17:1c9 |
0.31* |
|
|
0.39* |
0.33* |
|
|
|
|
18:0 |
|
|
|
−0.40** |
−0.41** |
|
|
|
|
18:1t6t8 |
|
|
|
|
|
0.32* |
|
|
|
18:1 t9 |
|
|
|
|
0.41* |
0.40* |
|
|
|
18:1 t10 |
|
−0.34* |
|
|
|
|
|
|
|
18:1 t11 |
|
|
|
|
|
|
|
|
|
18:1 t12 |
|
|
|
|
|
|
|
|
|
18:1c9 |
0.42** |
|
0.33* |
0.50** |
0.38* |
|
|
|
|
18:1c11 |
|
|
|
|
0.51** |
0.40* |
|
|
|
18:1c12 |
|
|
|
|
|
|
|
|
|
18:1c13 |
|
|
|
|
0.48** |
0.39* |
|
|
|
18:1t16c14 |
|
|
|
|
|
|
|
|
|
18:2n-6 |
|
|
|
−0.32* |
−0.53*** |
−0.52*** |
|
−0.33* |
|
20:0 |
|
|
|
|
0.48** |
0.68*** |
|
|
|
18:3n-3 |
|
|
|
|
−0.46** |
−0.50** |
|
|
|
20:1c11 |
|
|
|
|
|
0.38* |
|
0.32* |
0.38* |
20:2n-6 |
−0.59*** |
|
|
−0.46** |
−0.34* |
|
|
−0.38* |
|
20:3n-9 |
|
0.44** |
0.47** |
|
|
|
|
|
|
20:3n-6 |
|
|
|
|
0.50** |
0.67*** |
|
0.35* |
|
20:4n-6 |
|
|
|
|
|
|
|
|
0.34* |
23:0 |
|
|
|
|
|
|
|
|
|
20:5n-3 |
|
|
|
|
|
|
|
|
|
22:4n-6 |
−0.32* |
|
|
|
0.72*** |
0.70*** |
|
|
|
22:5n-3 | 0.32* |
1Statistical significance of Pearson correlation coefficients: *, P < 0.05; **, P < 0.01; ***, P < 0.001.
2Fatty acid contents expressed as mol/g liver.
3There were no significant correlations between SCD or SREBF1 and individual fatty acids.
4There were no significant correlations between 15:0, CLA (c9t11), 22:6n-3 and the mRNA levels of the genes under analysis.